Feature | August 05, 2014

GE Healthcare’s Integrated PET/MR System Pending FDA Review

August 5, 2014 — GE Healthcare announced its first integrated, simultaneous, time-of-flight (TOF) capable, whole-body Signa PET/MR (positron emission tomography/magnetic resonance) is 510(k) pending at the U.S. Food and Drug Administration (FDA).

Powered by simultaneous image acquisition from GE’s latest 3.0T MR and PET technologies, the Signa PET/MR helps clinicians achieve improved scan efficiency that may lead to more effective treatment paths for clinicians to offer their patients, particularly for oncology, neurology and cardiology.

MR is ideal for imaging soft tissue as well as functional and morphological details, while PET enables clinicians to visualize cellular activity and metabolism. When these two tools are combined, clinicians may be able to see early cellular changes that can be accurately mapped onto MR images. With this knowledge, clinicians may be able to shorten the time between diagnosis and treatment, in addition to offering the convenience of simultaneous PET and MR scans for patients. Research systems are installed at Stanford University, University of California San Francisco and University of Zurich.

“We are excited about Signa PET/MR because of its clinical and research potential,” said Andrei H. Iagaru, M.D., associate professor of radiology and co-chief of the division of nuclear medicine and molecular imaging at Stanford University Medical Center. “We have been using the system for research, and we are able to explore novel things in areas like neurology and oncology, as well as in pediatrics in the future. Additionally, it’s more convenient for the patient due to simultaneous scanning. We can also initiate innovative, complex research; simultaneity allows us to do functional neuro imaging, cardiac imaging and musculoskeletal imaging that we haven’t been able to do before. TOF offers improved image quality in PET/MR and with the increased detector sensitivity, it may lead to future improvements in dose reduction.”

The Signa PET/MR features GE’s new, exclusive MR-compatible silicon photomultiplier detector (SiPM) technology. This new digital detector is characterized by its enhanced sensitivity; it is up to three times more sensitive than conventional PET technology. It also features fast coincidence timing resolution enabling TOF reconstruction. With TOF reconstruction, the arrival times of each coincident pair of photons are more precisely detected, and the time difference between them is used to localize the PET signal accurately. TOF leads to improved PET image quality with higher structural detail and improved signal-to-noise ratio. The Siga PET/MR is designed to be fully upgradable from a Discovery MR750w 3.0T.

“We have received extremely positive feedback from our installations of the research PET/MR systems,” said Richard Hausmann, president and CEO of GE Healthcare MR. “Our research partners are very excited by the performance of the system and the potential of this new technology. We are proud to bring the first TOF-capable, simultaneous PET/MR system, pending FDA clearance, to market.”

The system is not available for sale in the United States and has not yet received CE mark. It is not available for sale in all regions.

For more information: www.gehealthcare.com

Related Content

GE Healthcare, general purpose digital SPECT/CT, Discovery NM/CT 670 CZT, Barnes-Jewish Hospital, first U.S. install
News | SPECT-CT| May 05, 2016
Doctors and researchers at Barnes-Jewish Hospital and Washington University in St. Louis may be able to better diagnose...
MR angiography, MRA, Bayer, Gadavist, gadobutrol injection, FDA approval, supra-aortic arteries
Technology | Contrast Media| April 29, 2016
Bayer announced that the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use...
UltraSPECT, 10th anniversary, WBR technology, Wide Beam Reconstruction, FDA approval, nuclear imaging
News | Nuclear Imaging| April 21, 2016
UltraSPECT Inc. announced the 10th anniversary of the U.S. Food and Drug Administration (FDA) approval of its Wide Beam...
News | Advanced Visualization| April 07, 2016
April 7, 2016 — Circle Cardiovascular Inc.
PET/CT scan, brain stress center, heart disease predictor, ACC.16
News | PET-CT| April 05, 2016
New research shows individuals with a greater degree of activity in the stress center of the brain also have more...
Toshiba, ACC 2016, American College of Cardiology, CT, MR, ultrasound, angiography, interventional radiology

Infinix 4-D CT image courtesy of Toshiba America Medical Systems.

News | Cardiac Imaging| March 30, 2016
Toshiba America Medical Systems Inc. announced it would demonstrate the following diagnostic imaging technologies at...
Duke University study, molecular lightbulbs, MRI imaging agent

Duke scientists have discovered a new class of inexpensive and long-lived molecular tags that enhance MRI signals by 10,000-fold. To activate the tags, the researchers mix them with a newly developed catalyst (center) and a special form of hydrogen (gray), converting them into long-lived magnetic resonance 'lightbulbs' that might be used to track disease metabolism in real time. Image courtesy of Thomas Theis, Duke University.

News | Magnetic Resonance Imaging (MRI)| March 28, 2016
Duke University researchers have taken a major step towards realizing a new form of magnetic resonance imaging (MRI)...
Circle Cardiovascular Imaging, GE Healthcare, licensing and distribution agreement, cmr42 software, cardiovascular MRI
News | Magnetic Resonance Imaging (MRI)| March 21, 2016
March 21, 2016 — Circle Cardiovascular Inc., developer of...
stroke damage, MRI, contrast agent, gelatinase, University of Missouri study
News | Stroke| March 16, 2016
A team of researchers led by the University of Missouri School of Medicine has developed a new, real-time method of...
Technavio market report, global medical imaging market, refurbished systems
News | March 10, 2016
According to the latest research study released by Technavio, the global medical imaging market is expected to reach...
Overlay Init